John LaRocca - Jan 6, 2025 Form 3 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
SVP, General Counsel & Secry
Signature
/s/ John LaRocca
Stock symbol
YMAB
Transactions as of
Jan 6, 2025
Transactions value $
$0
Form type
3
Date filed
1/16/2025, 04:44 PM
Previous filing
Nov 21, 2022
Next filing
Jan 22, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding YMAB Employee Stock Option (right to buy) Jan 6, 2025 Common Stock 143K $9.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 18, 2025, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney